Steven K. Libutti, MD
- Surgery-General | Surgery-Oncology
Dr. Libutti is the William N. Hait Director of Rutgers Cancer Institute and the Senior Vice President of Oncology Services, RWJBarnabas Health. Along with his leadership roles he is also a surgical oncologist with expertise in the management of cancer of the liver, pancreas, gastrointestinal (GI) tract, thyroid, parathyroid, and adrenal glands. He specializes in endocrine surgery and neuroendocrine tumors. Dr. Libutti strives to achieve a synergy between his clinical interests and his laboratory interests. For instance, when he is in the laboratory, he knows that he is studying the disease to help him become more effective at treating that disease. When he is in the clinic or the operating room, he is learning about the disease first hand by treating it. Dr. Libutti’s laboratory, which has been funded by the NCI for the past 20 years, studies the development and growth of neuroendocrine tumors in various models and strategies to develop novel cancer therapies through an understanding of the tumor microenvironment and blood vessel formation in tumors. After graduating magna cum laude from Harvard College, He received my medical degree from the College of Physicians and Surgeons of Columbia University. He remained at Presbyterian Hospital in New York where I completed my residency in surgery, followed by a fellowship at the NCI in surgical oncology and endocrine surgery. Before joining Rutgers Cancer Institute and RWJBarnabas Health he served as Director for the Montefiore Einstein Center for Cancer Care in New York City and was a Professor and Vice Chairman of the Department of Surgery and Professor in the Department of Genetics at Albert Einstein College of Medicine and Montefiore Health System. He has served as the President of the American Association of Endocrine Surgeons.
Clinical Interests:
Neuroendocrine tumors, thyroid cancer, parathyroid tumors, pancreatic cancer, liver cancer, gastrointestinal (GI) cancers, minimally invasive surgery, and clinical trials.
Columbia Univ College of Physicians and Surgeons, New York, NY
New York Presbyterian Columbia University Medical Center, New York, NY
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
New York Presbyterian Columbia University Medical Center, New York, NY
| Title: | Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease |
| Authors: | Keutgen XM, Hammel P, Choyke PL, Libutti SK, Jonasch E, Kebebew E. |
| Publisher: | Nat Rev Clin Oncol |
| Date: | 2016 |
| Issue: | |
| Description: | doi: 10.1038/nrclinonc.2016.37. [Epub ahead ofprint] Review. PubMed PMID: 27030075. |
| Title: | The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review |
| Authors: | Serrano OK, Love C, Goldman I, Huang K, Ng N, Abraham T, Da Silva R, Friedmann P, Libutti SK, Kennedy TJ |
| Publisher: | J Surg Oncol |
| Date: | 2016 |
| Issue: | 113(6):640-6 |
| Description: | doi: 10.1002/jso.24190. PubMed PMID: 27115836 |
| Title: | Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer |
| Authors: | Kwon M, Kim JH, Rybak Y, Luna A, Hun Choi C, Chung JY, Hewitt SM, Adem A, Tubridy E, Lin J, Libutti SK |
| Publisher: | Oncotarget |
| Date: | 2016 |
| Issue: | |
| Description: | doi: 10.18632/oncotarget.12784. [Epub ahead of print] PubMed PMID: 27776341. |
| Title: | Editorial: Treatment decision making in the era of genetic testing and molecular diagnostics |
| Authors: | Libutti SK |
| Publisher: | Surgery |
| Date: | 2017 |
| Issue: | 161(1):228-229 |
| Description: | doi: 10.1016/j.surg.2016. 10.009. PubMed PMID: 27863788 |
| Title: | Of mice and men(in) and what I have learned from both |
| Authors: | Libutti SK |
| Publisher: | Surgery |
| Date: | 2017 |
| Issue: | 161(1):1-11 |
| Description: | doi: 10.1016/j.surg.2016.10.004. PubMed PMID: 27865595. |
| Title: | 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect |
| Authors: | Chandra D, Selvanesan BC, Yuan Z, Libutti SK, Koba W, Beck A, Zhu K, Casadevall A, Dadachova E, Gravekamp C |
| Publisher: | Oncotarget |
| Date: | 2017 |
| Issue: | |
| Description: | doi: 10.18632/oncotarget.15117. [Epub ahead of print]. PubMed PMID: 28186976. |
| Title: | Sensitivity of 3-Dimensional Sonography in Preoperative Evaluation of Parathyroid Glands in Patients With Primary Hyperparathyroidism |
| Authors: | Frank SJ, Goldman-Yassen AE, Koenigsberg T, Libutti SK, Koenigsberg M |
| Publisher: | J Ultrasound Med. |
| Date: | 2017 |
| Issue: | |
| Description: | doi: 10.1002/jum.14245. [Epub ahead of print] PubMed PMID: 28543268 |
| Title: | Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary |
| Authors: | Singh S, Carnaghi C, Buzzoni R, Pommier RF, Raderer M, Tomasek J, Lahner H, Valle JW, Voi M, Bubuteishvili-Pacaud L, Lincy J, Wolin E, Okita N, Libutti SK, Oh DY, Kulke M, Strosberg J, Yao JC, Pavel ME, Fazio N |
| Publisher: | Neuroendocrinology, RAD001 in Advanced Neuroendocrine Tumors, Fourth Trial (RADIANT-4) Study Group |
| Date: | 2017 |
| Issue: | |
| Description: | doi: 10.1159/000477585. [Epub ahead of print.] PubMed PMID: 28554173 |
| Title: | Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas |
| Authors: | Wang H, Bender A, Wang P, Karakose E, Inabnet WB, Libutti SK, Arnold A, Lambertini L, Stang M, Chen H, Kasai Y, Mahajan M, Kinoshita Y, Fernandez-Ranvier G, Becker TC, Takane KK, Walker LA, Saul S, Chen R, Scott DK, Ferrer J, Antipin Y, Donovan M, Uzilov A |
| Publisher: | Nat Commun. |
| Date: | 2017 |
| Issue: | 3;8(1): 767 |
| Description: | doi: 10.1038/s41467-017-00992-9. PubMed PMID: 28974674 |
| Title: | Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors |
| Authors: | Salazar R, Garcia-Carbonero R, Libutti SK, Hendifar AE, Custodio A, Guimbaud R, Lombard-Bohas C, Ricci S, Klümpen HJ, Capdevila J, Reed N, Walenkamp A, Grande E, Safina S, Meyer T, Kong O, Salomon H, Tavorath R, Yao JC |
| Publisher: | The Oncologist |
| Date: | 2017 |
| Issue: | |
| Description: | pii: theoncologist.2017-0144. doi: 10.1634/theoncologist.2017-0144. [Epub ahead of print] PubMed PMID: 29242283 |
| Title: | Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-LindauDisease |
| Authors: | Tirosh A, Sadowski SM, Linehan WM, Libutti SK, Patel D, Nilubol N, Kebebew E |
| Publisher: | JAMA Oncol. |
| Date: | 2018 |
| Issue: | 4(1):124-126 |
| Description: | doi:10.1001/jamaoncol.2017.3428. PubMed PMID: 29075773 |
| Title: | Injection of bulking agents for laryngoplasty |
| Authors: | Snyder SK, Angelos P, Carty SE, Doherty GM, Howe JR, Lee JA, Libutti SK, Miller BS, Parangi S, Patel KN, Sippel RC, Sturgeon C, Wang TS, Yip L, Zeiger MA |
| Publisher: | Surgery |
| Date: | 2018 |
| Issue: | 163(1):6-8 |
| Description: | doi: 10.1016/ j.surg.2017.08.019. Epub 2017 Nov 9. PubMed PMID: 29129367 |
| Title: | Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model |
| Authors: | Maggi EC, Gravina S, Cheng H, Piperdi B, Yuan Z, Dong X, Libutti SK, Vijg J, Montagna C |
| Publisher: | Front Genet. |
| Date: | 2018 |
| Issue: | 23;9:6 |
| Description: | doi: 10.3389/fgene.2018.00006. eCollection 2018. PMID: 29410677 |
Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.